glp-1 weight loss risks Drugs and Eating Disorders: A Hidden Risk in the Revolution – The Chicago Council on Science and Technology Should I take a GLP-1

These medications were originally developed for type 2 diabetes but are now widely used for medical weight loss

& Shu, L

Elevated levels of ferritin and transferrin, markers of iron dysregulation, have been observed in clinical ARDS cases, linking iron metabolism to disease severity ( Mitochondrial dysfunction exacerbates iron-driven ferroptosis by impairing the organelles ability to sequester and regulate iron levels

The review further examines safety and tolerability data reported across these trials, focusing particularly on gastrointestinal side effects and emerging considerations such as reductions in lean body mass accompanying substantial weight loss

Is ferroptosis caused exclusively by an excessive lipid peroxides accumulation due to GSH depletion and oxidative damage, or also by cysteine insufficiency itself